Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above

Authors: Desmond Curran, Ruprecht Schmidt-Ott, Ulf Schutter, Jörg Simon, Anastassia Anastassopoulou, Sean Matthews

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Herpes zoster (HZ) is a painful dermatomal rash caused by reactivation of latent varicella zoster virus surviving in the patient’s sensory ganglia after a previous episode of varicella. The incidence of HZ increases markedly with age as does the proportion of HZ patients who develop postherpetic neuralgia (PHN) with often severe and debilitating pain persisting for months and even years.
This prospective study aimed to assess the impact of HZ and PHN on the quality of life (QoL) of individuals aged ≥ 50 years in Germany.

Methods

Patients were recruited when consulting primary care physicians for a first HZ episode. PHN was defined as a ‘worst’ pain score ≥ 3 on the Zoster Brief Pain Inventory (ZBPI) scale persisting or appearing 90 days or more after rash onset. PHN-cases were followed for up to nine months after rash onset. The interference of pain with patients’ ability to carry out normal activities was assessed by the ZBPI activities of daily living (ADL) scale and QoL by the EuroQoL five-dimension scale (EQ-5D) utility score.

Results

Of 513 patients enrolled, 61 (11.9%) developed PHN. At HZ onset, the mean ZBPI worst pain score of all patients was 5.1, the least square (LS)means estimates of the ZBPI ADL and EQ-5D utility scores were 2.970 and 0.740, respectively. Over three months follow-up, the pain scores decreased and the QoL increased monotonically across all age groups. At Day 90, the mean ZBPI worst pain score of the PHN patients was 4.4, while the LSmeans estimates of the ZBPI ADL and EQ-5D utility scores were 2.899 and 0.826, respectively. For patients with PHN persisting at nine months, the pain scores and QoL remained unchanged over the six months following the development of PHN.

Conclusion

HZ and PHN had a substantial impact on the patients’ QoL and ability to function in their normal activities. There was a clear association in time between the evolution of pain and estimated QoL. The impact on ADL and QoL did not vary with age.
Appendix
Available only for authorised users
Literature
2.
go back to reference Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiology Rev. 2013;26:728–43.CrossRef Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiology Rev. 2013;26:728–43.CrossRef
3.
go back to reference Johnson RW, Bouhassira D, Kassianos G, Leplege A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37.CrossRef Johnson RW, Bouhassira D, Kassianos G, Leplege A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37.CrossRef
4.
go back to reference Mick G, Hans G. Postherpetic neuralgia in Europe: the scale of the problem and outlook for the future. J Clin Geron Geriat. 2013;4:102–8.CrossRef Mick G, Hans G. Postherpetic neuralgia in Europe: the scale of the problem and outlook for the future. J Clin Geron Geriat. 2013;4:102–8.CrossRef
5.
go back to reference Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995;45(Suppl. 8):S52–3.CrossRef Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995;45(Suppl. 8):S52–3.CrossRef
6.
go back to reference Bouhassira D, Chassany O, Gaillat J, Hanslik T, Launay O, Mann C, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2012;153:342–9.CrossRef Bouhassira D, Chassany O, Gaillat J, Hanslik T, Launay O, Mann C, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2012;153:342–9.CrossRef
7.
go back to reference Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wickmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.CrossRef Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wickmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.CrossRef
8.
go back to reference Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and post-herpetic neuralgia on patients’ quality of life: a patient-reported outcomes survey. J Public Health. 2010;18:367–74.CrossRef Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and post-herpetic neuralgia on patients’ quality of life: a patient-reported outcomes survey. J Public Health. 2010;18:367–74.CrossRef
10.
go back to reference Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res. 2013;13:359.CrossRef Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res. 2013;13:359.CrossRef
11.
go back to reference Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731–6.CrossRef Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731–6.CrossRef
12.
go back to reference Schmidt-Ott R, Schutter U, Simon J, Nautrup BP, von Krempelhuber A, Gopala K, Anastassopoulou A, Guignard A, Curran D, Matthews S, Espié E. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: a prospective study. J Inf Secur. 2018;76(5):475–82. Schmidt-Ott R, Schutter U, Simon J, Nautrup BP, von Krempelhuber A, Gopala K, Anastassopoulou A, Guignard A, Curran D, Matthews S, Espié E. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: a prospective study. J Inf Secur. 2018;76(5):475–82.
13.
go back to reference Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5:344–56.CrossRef Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5:344–56.CrossRef
14.
go back to reference Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33:337–43.CrossRef Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33:337–43.CrossRef
16.
go back to reference Zwinderman AH. The measurement of change of quality of life in clinical trials. Stat Med. 1990;9:931–42.CrossRef Zwinderman AH. The measurement of change of quality of life in clinical trials. Stat Med. 1990;9:931–42.CrossRef
17.
go back to reference Zwinderman AH. Statistical analysis of longitudinal quality of life data with missing measurements. Qual Life Res. 1992;1:219–24.CrossRef Zwinderman AH. Statistical analysis of longitudinal quality of life data with missing measurements. Qual Life Res. 1992;1:219–24.CrossRef
18.
go back to reference Curran D, Molenberghs G, Aaronson NK, Fossa SD, Sylvester RJ. Analysing longitudinal continuous quality of life data with dropout. Stat Methods Med Res. 2002;11:5–23.CrossRef Curran D, Molenberghs G, Aaronson NK, Fossa SD, Sylvester RJ. Analysing longitudinal continuous quality of life data with dropout. Stat Methods Med Res. 2002;11:5–23.CrossRef
19.
go back to reference Curran D, Molenberghs G, Thijs H, Verbeke G. Sensitivity analysis for pattern mixture models. J Biopharm Stat. 2004;14:125–43.CrossRef Curran D, Molenberghs G, Thijs H, Verbeke G. Sensitivity analysis for pattern mixture models. J Biopharm Stat. 2004;14:125–43.CrossRef
20.
go back to reference Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer Verlag; 2002. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer Verlag; 2002.
21.
go back to reference Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass. 1958;53:457–81.CrossRef Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass. 1958;53:457–81.CrossRef
22.
go back to reference Vujacich C, de Wouters L, Margari A, Gordovil M, Kawai K, Lemos E et al. Assessment of burden of illness due to herpes zoster in Argentina: a prospective observational study. Value Health 2013;16:A668 (Abstract only).CrossRef Vujacich C, de Wouters L, Margari A, Gordovil M, Kawai K, Lemos E et al. Assessment of burden of illness due to herpes zoster in Argentina: a prospective observational study. Value Health 2013;16:A668 (Abstract only).CrossRef
23.
go back to reference Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23–30.CrossRef Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23–30.CrossRef
24.
go back to reference Gater A, Abetz-Webb L, Carroll S, Mannan A, Serpell M, Johnson R. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis. 2014;14:40.CrossRef Gater A, Abetz-Webb L, Carroll S, Mannan A, Serpell M, Johnson R. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis. 2014;14:40.CrossRef
25.
go back to reference Tsai TF, Yao CA, Yu HS, Lan CC, Chao SC, Yang JH, et al. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study. Int J Dermatol. 2015;54:529–36.CrossRef Tsai TF, Yao CA, Yu HS, Lan CC, Chao SC, Yang JH, et al. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study. Int J Dermatol. 2015;54:529–36.CrossRef
26.
go back to reference Gu NY, Bell C, Botteman MF, Ji X, Carter JA, van Hout B. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. Patient. 2012;5:185–97.PubMed Gu NY, Bell C, Botteman MF, Ji X, Carter JA, van Hout B. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. Patient. 2012;5:185–97.PubMed
27.
go back to reference van Seventer R, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006;35:132–7.CrossRef van Seventer R, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006;35:132–7.CrossRef
28.
go back to reference Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. J Public Health. 2012;20:441–51.CrossRef Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. J Public Health. 2012;20:441–51.CrossRef
29.
go back to reference Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–32.CrossRef Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–32.CrossRef
30.
go back to reference Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O’Brien B. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol. 1998;51:667–76.CrossRef Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O’Brien B. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol. 1998;51:667–76.CrossRef
31.
go back to reference Oster G, Harding G, Dukes E, Edlesberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005;6:356–63.CrossRef Oster G, Harding G, Dukes E, Edlesberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005;6:356–63.CrossRef
32.
go back to reference Pellissier JM, Brisson M, Levin MJ. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine. 2007;25:8326–37.CrossRef Pellissier JM, Brisson M, Levin MJ. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine. 2007;25:8326–37.CrossRef
33.
go back to reference Serpell M, Gater A, Carroll S, Abetz-Webb L, Mannan A, Johnson R. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. Health Qual Life Outcomes. 2014;12:92.CrossRef Serpell M, Gater A, Carroll S, Abetz-Webb L, Mannan A, Johnson R. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. Health Qual Life Outcomes. 2014;12:92.CrossRef
34.
go back to reference König HH, Heider D, Lehnert T, Riedel-Heller S, Angermeyer MC, Matschinger H, et al. Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual Life Outcomes. 2010;8:143.CrossRef König HH, Heider D, Lehnert T, Riedel-Heller S, Angermeyer MC, Matschinger H, et al. Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual Life Outcomes. 2010;8:143.CrossRef
35.
go back to reference Dworkin RH, Hartstein G, Rosner HL, Walther RR, Sweeney EW, Brand L. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol. 1992;101:200–5.CrossRef Dworkin RH, Hartstein G, Rosner HL, Walther RR, Sweeney EW, Brand L. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol. 1992;101:200–5.CrossRef
36.
go back to reference Schmader K, Gnann JW, Jr WCP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197(Suppl 2):S207–15.CrossRef Schmader K, Gnann JW, Jr WCP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197(Suppl 2):S207–15.CrossRef
37.
go back to reference Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342–8.CrossRef Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342–8.CrossRef
38.
go back to reference Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23:490–6.CrossRef Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23:490–6.CrossRef
39.
go back to reference Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine. 2014;32:1645–53.CrossRef Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine. 2014;32:1645–53.CrossRef
41.
go back to reference Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531–48.CrossRef Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531–48.CrossRef
Metadata
Title
Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above
Authors
Desmond Curran
Ruprecht Schmidt-Ott
Ulf Schutter
Jörg Simon
Anastassia Anastassopoulou
Sean Matthews
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3395-z

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue